Members
The WGND is composed of diverse interested stakeholders in TB drug development, including those working in TB drug R&D, regulators, public health workers, funders, community representatives, advocates and policy-makers.
The WGND membership rests with individuals, not institutions. Thus, the WGND has no "lead agency" and is not dominated by any institution or group of institutions. Members represent the private and public sectors and come from diverse geographical locations.
Apply Now Learn More View Core GroupCurrent Members
Name
|
Organization | Country |
|---|---|---|
| Daniel Zollinger | QareFree | Netherlands |
| Oren Zimhony | Kaplan Medical Center, The School of Medicine Hebrew University | Israel |
| Ying Zhang | Johns Hopkins University | United States |
| Xuelian Zhang | Fudan University | China |
| Jerome Zeldis | Celgene | United States |
| Claire Wingfield | PATH | United States |
| Sharon Williams | National Institute for Allergy and Infectious Diseases (NIH/NIAID) | United States |
| Nicolas Willand | Institut Pasteur Lille | France |
| Richard White | London School of Hygiene and Tropical Medicine | United Kingdom |
| Charles Wells | Sanofi | United States |
| Peter Warner | Bill and Melinda Gates Foundation | United States |
| Tiansheng Wang | Vertex Pharmaceuticals | United States |
| Steve Wandiga | KEMRI/CDC | Kenya |
| Joshua Wamboga | Uganda Network of AIDS Service Organisations (UNASO) | Uganda |
| Gerhard Walzl | Stellenbosch University | South Africa |
| Robert Wallis | Aurum Institute | South Africa |
| Kristina Wallengren | THINK | South Africa |
| Todd Waldman | Easton Associates | United States |
| Dalene von Delft | TB Proof | South Africa |
| Laura Via | National Institute for Allergy and Infectious Diseases (NIH/NIAID) | United States |
| Andrew Vernon | U.S. Centers for Disease Control and Prevention (CDC) | United States |
| Gustavo E. Velásquez | University of California, San Francisco | USA |
| Wim Vandevelde | European AIDS Treatment Group (EATG); Community Representative | South Africa |
| Brian VanderVen | Cornell University | United States |
| Omar Vandal | Bill and Melinda Gates Foundation | United States |
| Christo van Niekerk | TB Alliance | South Africa |
| Astrid Van der Sar | VU University Medical Center | Netherlands |
| Anna Upton | TB Alliance | United States |
| Manjunatha Ujjini | Novartis Institute for Tropical Diseases | Singapore |
| Oleg Tsodikov | University of Kentucky | United States |
| Tamari Trapaidze | Welfare Foundation | Georgia |
| Simon Tiberi | Barts Healthcare NHS Trust | United Kingdom |
| Gail Tauscher | National Institute for Allergy and Infectious Diseases (NIH/NIAID) | United States |
| Rajneesh Taneja | TB Alliance | United States |
| John Szumowski | Santa Clara Valley Medical Center | United States |
| Hulda Swai | Council of Scientific Industrial Research (CSIR) in South Africa | South Africa |
| Martin Springsklee | Bayer Healthcare | United States |
| Melvin Spigelman | TB Alliance | United States |
| Nelly Solomonia | National Center for Tuberculosis and Lung Diseases | Georgia |
| Christine Sizemore | Fogarty International Center at NIH | United States |
| Tado Shimao | Japan Anti-Tuberculosis Association (JATA) Research Institute of TB | Japan |
| David Sherman | University of Washington | United States |
| Boitumelo Semete | Council of Scientific Industrial Research (CSIR) in South Africa | South Africa |
| Cherise Scott | TB Alliance | United States |
| Dirk Schnappinger | Weill Cornell Medical College | United States |
| Dario Scaramuzzi | R-Evolution Group EEIG | Italy |
| Kampasati Satyanarayana | Yuvabharath Society | India |
| Christopher Sassetti | University of Massachusetts Medical School | United States |
| Roberto Salvino | No affiliation | Philippines |
| Sandeep Saluja | No affiliation | India |
| David Russell | Cornell University | United States |
| Samir Roy | Government Medical College, Bhavnagar | India |
| Doris Rouse | RTI International | United States |
| Brian Robertson | Imperial College London | United Kingdom |
| Kyu Rhee | Weill Cornell Medical College | United States |
| Klaus Reither | Swiss Tropical and Public Health Institute | Tanzania |
| Mario Raviglione | Università degli Studi di Milano | Switzerland |
| Kanury Rao | International Centre for Genetic Engineering & Biotechnology-New Delhi | India |
| Santiago Ramón García | Research Agency of Aragon (ARAID) | Spain |
| Ravishankar Ramachandran | CSIR-Central Drug Research Institute, Lucknow, India | India |
| Dhanji Rajani | Microcare Laboratory | India |
| Marina Protopopova | National Institute for Allergy and Infectious Diseases (NIH/NIAID) | United States |
| Matthew Price | Harvard School of Public Health | United States |
| Kevin Pethe | Institut Pasteur-Korea | South Korea |
| Liyanage Perera | National Institutes of Health (NIH) | United States |
| Fernando Pavan | Sao Paulo State University, UNESP, Brazil | Brazil |
| Prasad Pasam | Shar Technologies Group | India |
| Tanya Parish | Infectious Disease Research Institute (IDRI) | United States |
| Shreemanta Parida | Clinical Scientist | India |
| Frances Pappas | TB Alliance | United States |
| Rogelio Hernandez Pando | National Institute of Medical Sciences and Nutrition, Mexico | Mexico |
| Prasit Palittapongarnpim | Mahidol University | Thailand |
| Nelson Otwoma | Positive Familes Network (+FN) | Kenya |
| Regina Osih | Clinton Health Access Initiative | South Africa |
| Diane Ordway | Colorado State University | United States |
| Philip Onyebujoh | WHO Regional Office for Africa | Zimbabwe |
| Abdifetah Ibrahim Omer | National TB Programme Somalia | Somalia |
| Iain Old | Innovative Medicines for TB (iM4TB) | Switzerland |
| Masaji Okada | Clinical Research Center, National Hospital Organization Kinki-Chuo Chest Medical Center | Japan |
| Dorothy Odhiambo | International Community of Women Living with HIV in Kenya ( ICW-K) | Kenya |
| Ronan O'Toole | Trinity College Dublin | Ireland |
| Rick O'Brien | Switzerland | |
| Eric Nuermberger | Johns Hopkins University | United States |
| Michaela Nielsen | Regulatory Affairs Consultant | United States |
| Carl Nathan | Weill Cornell Medical College | United States |
| Edward Nardell | Partners in Health | United States |
| P. R. Narayanan | Tuberculosis Research Centre, Chennai (retired) | India |
| Payam Nahid | University of California, San Francisco | United States |
| Carol Nacy | Sequella, Inc. | United States |
| Benson Muriuki | Center for the Empowerment Of The Local Herbalist-Celoh Kenya | Kenya |
| Ute Muh | University of Iowa | United States |
| Roger Moses | iThemba Pharmaceuticals | United Kingdom |
| Heinz Moser | Achaogen | United States |
| Valerie Mizrahi | UCT-Institute of Infectious Disease and Molecular Medicine | South Africa |
| Carole Mitnick | Harvard Medical School | United States |
| Arun Kumar Mishra | University of Birmingham | United Kingdom |
| Khisimuzi Mdluli | Bill and Melinda Gates Medical Research Institute | United States |
| David McNeeley | Medical Service Corportation International (MSCI) | United States |
| Maggie McCammon | Michigan Economic Development Corporation | United States |
| Stephen Matlin | Global Forum for Health Research | Switzerland |
| Mohammad Hassan Mashori | Fundamental Human Rights & Rural Development Association (FHRRDA) | Pakistan |
| Bonita Mangura | Global TB Institute at UMDNJ | United States |
| Shekhar Mande | National Centre for Cell Science | India |
| Teto Fondacaro Mamona | Programme National de Lutte Contre la Tuberculose | Democratic Republic Of Congo (Zaire) |
| Albert Makone | Community Representative; Global Fund (local) | Zimbabwe |
| Alick Chimpimo Makiyi | Grassroots Movement for Health and Development (GMHD) | Malawi |
| Mamodikoe Makhene | National Institute for Allergy and Infectious Diseases (NIH/NIAID) | United States |
| Parameshwar Makam | University of KwaZulu-Natal | South Africa |
| Htay Lwin | National TB Program, Myanmar | Myanmar (Burma) |
| Shichun Lun | Johns Hopkins University School of Medicine | United States |
| Doug Lowrie | Fudan University's Shanghai Public Health Clinical Center | China |
| James Love | Knowledge Ecology International (KEI) | United States |
| Nino Lomtadze | National Center for Tuberculosis and Lung Diseases | Georgia |
| Christopher Locher | Baxalta | United States |
| Christian Lienhardt | World Health Organization (WHO) | Senegal |
| Francisco Leyva | National Institute for Allergy and Infectious Diseases (NIH/NIAID) | United States |
| Erica Lessem | Treatment Action Group | United States |
| Anne Lenaerts | Colorado State University | United States |
| Didier Leboulleux | Sanofi | France |
| Barbara Laughon | National Institute for Allergy and Infectious Diseases (NIH/NIAID) | United States |
| Gyanu Lamichhane | Johns Hopkins University | United States |
| Galyna Kutsyna | Luhansk State Medical University | Ukraine |
| Anil Koul | Johnson and Johnson | Belgium |
| Sergey Koren | JSC Pharmasyntez | Russia |
| Sang Jae Kim | Korean Institute of Tuberculosis | South Korea |
| Ahmadul Khan | Ahmadul Hasan Khan | Bangladesh |
| Basharat Khan | National TB Control Programme | Pakistan |
| Hiromu Kawakubo | Asahi Kasei Chemicals Corporation | Japan |
| Victoria Kasprowicz | SANTHE | South Africa |
| Petros Karakousis | Johns Hopkins University School of Medicine | United States |
| Gilla Kaplan | United States | |
| Shashi Kant | UT Southwestern Medical Center | United States |
| Takushi Kaneko | TB Alliance | United States |
| Bavesh Kana | University of the Witwatersrand/National Health Laboratory Service | South Africa |
| Rajender Kamboj | Lupin Limited | India |
| Yadav Prasad Joshi | Biodyss and Journal Infection in Developing Countries | France |
| KR John | SRM Medical College | India |
| Amina Jindani | St. George's, University of London | United Kingdom |
| Josef Jampilek | Comenius University | Slovakia |
| Mary Jackson | Colorado State University | United States |
| Daniela Jabes | NeED Parma | Italy |
| Robert Husson | Children's Hospital Boston/Harvard Medical School | United States |
| Gary Horwith | BARDA | United States |
| C. Robert Horsburgh | Boston University School of Public Health | United States |
| Michael Hoelscher | Ludwig-Maximilians-University | Germany |
| Philip Hipskind | Lgenia | United States |
| Anneke Hesseling | Desmond Tutu TB Centre | South Africa |
| Sonja Henne | MSF | Tunisia |
| Norbert Heinrich | Universtiy of Munich / PanACEA | Germany |
| Mark Harrington | Treatment Action Group | United States |
| Nii Nortey Hanson-Nortey | Ghana Health Service | Ghana |
| Debra Hanna | Bill and Melinda Gates Foundation | United States |
| Juan David Guzman | Birkbeck College | United Kingdom |
| Shashank Gupta | Brown University | United States |
| Tawanda Gumbo | Baylor University | United States |
| Malgosia Grzemska | World Health Organization (WHO) | Switzerland |
| Jacques Grosset | Scientist | France |
| Hugo Cesar Gramajo | Instituto de Biologia Molecular y Celular de Rosario | Argentina |
| Martin Graham | KinderPharm | United States |
| Bob Goldman | RCG Consulting | United States |
| Marc Gitzinger | BioVersys AG | Switzerland |
| Ann Ginsberg | IAVI | United States |
| Jan Gheuens | Bill & Melinda Gates Foundation | United States |
| Bolin Geng | Ra Pharma | United States |
| Lawrence Geiter | Otsuka Pharmaceutical Company | United States |
| Sylvie Garneau-Tsodikova | University of Michigan | United States |
| James Frincke | Hollis Eden Pharmaceuticals | United States |
| Joel Freundlich | UMDNJ - New Jersey Medical School | United States |
| Maria Freire | Foundation for NIH | United States |
| Scott Franzblau | Institute for Tuberculosis Research, University of Illinois at Chicago | United States |
| Bernard Fourie | University of Pretoria | South Africa |
| Muhammad Farooq | Government of Pakistan | Pakistan |
| Kolawole Ekanoye | Advocates for Health and Development Initiative | Nigeria |
| Leo Einck | Sequella, Inc. | United States |
| Chris Edlin | iThemba Pharmaceuticals | South Africa |
| Ken Duncan | Bill & Melinda Gates Foundation | United States |
| Carol Dukes Hamilton | Family Health International | United States |
| Andriy Dudnyk | National Medical University of Vinnytsia, Ukraine | Ukraine |
| Valerie Flore Donkeng Donfack | Pasteur Center in Cameroon | Cameroon |
| Martin Dolezal | Charles University in Prague, Faculty of Pharmacy in Hradec Kralove | Czech Republic |
| Noroi Doi | Japan Anti-Tuberculosis Association (JATA) Research Institute of TB | Japan |
| Chris Dippel | Peloton Partnering, SP | United States |
| Thomas Dick | University in New Jersey UMDNJ-New Jersey Medical School | United States |
| Marcio Dias | University of Sao Paulo | Brazil |
| Andreas Diacon | University of Stellenbosch | South Africa |
| Neeraj Dhar | École Polytechnique Fédérale de Lausanne (EPFL) | Switzerland |
| Brigitte Demers | Sanofi | France |
| Oscar Della Pasqua | GlaxoSmithKline | United Kingdom |
| Jurriaan de Steenwinkel | Erasmus MC | Netherlands |
| Mary Ann de Groote | Colorado State University | United States |
| Aboubacar Sidiki Daffe | Université Cheikh Anta DIOP | Senegal |
| Kobina Bosumtwi Dadzie | Wiljok Childaid and Health Organization | Ghana |
| Michael Cynamon | VAMC, SUNY, Upstate Medical University | United States |
| Christopher Cooper | Global Alliance for TB Drug Development (TB Alliance) | United States |
| Stewart Cole | Institut Pasteur | Switzerland |
| Polly Clayden | HIV i-Base | United Kingdom |
| Jeffery Cirillo | Texas A&M Health Science Center | United States |
| Isabelle Cieren-Puiseux | Sanofi | France |
| Sidharth Chopra | Central Drug Research Institute, Lucknow | India |
| Sang Nae Cho | Yonsei University College of Medicine | South Korea |
| William Chamberlin | Texas Tech University Health Sciences Center | United States |
| Richard Chaisson | Johns Hopkins University Center for TB Research | United States |
| Joan A. Cayla | Agència de Salut Pública de Barcelona | Spain |
| Kenneth Castro | Emory University | United States |
| Gail Cassell | Infectious Disease Research Institute (IDRI) | United States |
| Allen Casey | Infectious Disease Research Institute (IDRI) | United States |
| Alexandra Carreau | Sanofi-Adventis R&D | France |
| Pere-Joan Cardona | Institut Germans Trias i Pujol (IGTP) | Spain |
| Barry Bunin | Collaborative Drug Discovery | United States |
| Jim Boyce | National Institute for Allergy and Infectious Diseases (NIH/NIAID) | United States |
| Yap Boum II | Epicentre/MSF | Uganda |
| Renaud Boulanger | McGill University | Canada |
| Helena Boshoff | National Institutes of Health (NIH) | United States |
| Florence Bordon-Pallier | Sanofi | France |
| Martin Johan Boeree | PanACEA Consortium and the Radboud University Nijmegen Medical Centre | Netherlands |
| Amy Bloom | United States Agency for International Development (USAID) | United States |
| Jonathan Blackburn | University of Cape Town | South Africa |
| Gill Black | Sustainable Livelihoods Foundation | South Africa |
| William Bishai | Johns Hopkins School of Medicine | United States |
| Khadar Bhatcha | PSG College of Pharmacy | India |
| Sanjib Bhakta | The Institute of Structural and Molecular Biology, Birkbeck, University of London | United Kingdom |
| Edward Berry | SUNY Upstate Medical University | United States |
| Anthony Baughn | University of Minnesota | United States |
| Robert Bates | GlaxoSmithKline | Spain |
| Clifton Barry | National Institute for Allergy and Infectious Diseases (NIH/NIAID) | United States |
| David Barros | GlaxoSithKline | Spain |
| Jing Bao | Frontier Biotechnologies, LLC | United States |
| Cathy Bansbach | Bill & Melinda Gates Foundation | United States |
| Lluís Ballell | GlaxoSmithKline Tres Cantos | Spain |
| Tanjore Balganesh | CSIR-OSDD | India |
| Yossef Av-Gay | University of British Columbia | Canada |
| Asghar Arif | TB Association Charsadda Pak | Pakistan |
| Koen Andries | Janssen | Belgium |
| Avishek Anant | Novartis | India |
| Zahoor Ahmed | National TB Control Programme | Pakistan |
| Asaad Khalid Ahmed | National Center for Research | Sudan |
| Ibrahim Abubakar | University College London, MRC Clinical Trials Unit | United Kingdom |
| Tarek Aboul-Fadl | Medicinal Chemistry, Assiut University | Egypt |
New Members
The Working Group pipeline is open to anyone who is developing a TB drug. If you would like to become a member, please submit an application.
Apply NowQuestions? Contact Us